Recommendation ID
IPG383/1
Question
Further research into hand allotransplantation should include data on long-term functional outcomes, and any occurrence of malignancy associated with long-term immunosuppression should be published. NICE may review this procedure on publication of further evidence.
Any explanatory notes
(if applicable)
Current evidence on the efficacy and safety of hand allotransplantation is inadequate in quantity. In addition, there are risks from the prolonged immunosuppression required after the procedure. Therefore this procedure should only be used with special arrangements for clinical governance, consent and research.

Source guidance details

Comes from guidance
Hand allotransplantation
Number
IPG383
Date issued
March 2011

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No